US-based biopharmaceutical company Allergan has completed the acquisition of LifeCell, the regenerative medicine unit of Acelity.
Acelity’s regenerative medicines business and dermal matrix products are added to Allergan’s portfolio as a result of the acquisition.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Biopharmaceutical services provider Parexel International is set to acquire The Medical Affairs Company (TMAC), a full-service contract medical services provider founded in 2007 and based in the US.
Parexel intends to gain new and distinct medical affairs outsourcing capabilities through the acquisition.
